Biopharma Moves to Integrated, Single-Use, Downstream Processing
June 13, 2014 - By: Cynthia Challener, PhD BioPharm International
Biopharma Takes a Nervous Glance Over Its Shoulder
The US biopharmaceutical indust
May 19, 2014 - by: Rita Peters, BioPharm International
Changes are needed to maintain US biopharma innovation leadership.
Novel Vaccine Technologies Meet the Need for Pandemic and Therape
May 18, 2014 - By: Cynthia Challener, PhD, BioPharm International
New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.
Q&A with Industry Leader Konstantin Konstantinov, Genzyme Vice-Pr
May 1, 2014 - Process Development Forum
This week we speak with Konstantin Konstantinov, Genzyme Vice-President Late Stage Process Development, about developments in continuous processing.
…
Biopharma Outsourcing Activities Update
April 20, 2014 - Eric Langer, BioPharm International
Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.
Over the past
…
Quality by Design—Bridging the Gap between Concept and Implemen
April 20, 2014 - Sean Milmo BioPharm International
The drive to embed quality-by-design (QbD) principles into the pharmaceutical regulatory framework of the European Union has reached a key point 10 years after the E
…
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
April 20, 2014 - Cynthia Challener, PhD BioPharm International
Raw Material Variability
April 20, 2014 - Simon Chalk, BioPharm International
The biopharmaceutical industry is developing a new approach to controlling variability in raw materials.
Trends in BioPharma Approvals in 2013
April 7, 2014 - Gary Walsh, PhD , BioPharm International Magazine
In 2013, 20 products containing new biopharmaceutical molecular entities (defined herein as recombinant proteins, monoclonal antibody or biosynthesized nucleic acid
…
Q&A with Industry Leaders: Rita Peters
April 4, 2014 - Process Development Forum
This week, Process Development Forum's new Q&A feature interviews Rita Peters, Editor of BioPharm International Magazine, about second quarter trends in dr
…